Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a ...

First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ImmutepGlobal Phase III with ...

Among the many marvels of life is the cell's ability to divide and thus enable organisms to grow and renew themselves. For ...

For successful cell division, chromosomal DNA needs to be packed into compact rod-shaped structures. Defects in this process ...

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...

Life takes shape with the motion of a single cell. In response to signals from certain proteins and enzymes, a cell can start ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.

Feb. 4, 2025 — Researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the ... Jan. 31, 2025 — Prolonged ...

The researchers observed that light activated the enzyme, causing predictable cell movements. For example, specific light ...